Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination Cagrilintide and semaglutide together drive record weight loss in global trial Semaglutide vs Tirzepatide Pro Peptides Plus Novo Nordisk's CagriSema Falls Short in Head to Head Trial vs Zepbound Bryce Platt, PharmD posted on the topic LinkedIn Retatrutide vs. Tirzepatide: The Next Gen GLP 1 Showdown